News & Events

The Firm is representing the lender in connection with the bridge financing for Boston Scientific Corporation to finance its announced acquisition of BTG plc. 

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Boston Scientific Corporation’s products and technologies are used to diagnose or treat a wide range of medical conditions, including cardiovascular, digestive, respiratory, urological, pelvic health and neurological conditions.

BTG is a global healthcare company focused on interventional medicine. BTG’s portfolio of products advance the treatment of cancer and vascular conditions. BTG’s pharmaceuticals business provides products that help patients overexposed to certain medications or toxins.

The Simpson Thacher team includes Patrick Ryan, Eric Wisotsky and Jonathan Zane (Banking and Credit); and Roxane Reardon, Matthew Levy, Daniel Areshenko and Mary-Jane Rabeony (Capital Markets).